Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.

Archives of pathology & laboratory medicine - 1 May 2015

Chastain Elizabeth C, Duncavage Eric J

Abstract excerpt

CONTEXT: Diffuse large B-cell lymphoma and chronic lymphocytic leukemia are 2 of the most common B-cell lymphomas in adults. Both diffuse large B-cell lymphoma and chronic lymphocytic leukemia share heterogeneous outcomes, and the use of prognostic biomarkers to better stratify risk in these patients has now become commonplace. OBJECTIVE: To review chronic lymphocytic leukemia and diffuse large B-cell lymphoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Chromosome Aberrations
Share to Cytogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Lymphoma, Large B-Cell, Diffuse

Source

Identifiers

PMID: 25248094
DOI: 10.5858/arpa.2014-0086-RA

Genes

BCL2
BCL6
MYC
NOTCH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.PMID 25248094Read ↗

Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markersSemantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

[Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia].Semantic proximity Read ↗

Prognostic factors and risk stratification in chronic lymphocytic leukemia.Semantic proximity Read ↗

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.Semantic proximity Read ↗

An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted TherapySemantic proximity Read ↗

Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic StrategiesSemantic proximity Read ↗

Molecular biomarkers in chronic lymphocytic leukemia.Semantic proximity Read ↗

Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.